SPECGX LLC FDA Approval NDA 017090

NDA 017090

SPECGX LLC

FDA Drug Application

Application #017090

Documents

Letter2004-03-28
Letter2007-07-24
Letter2012-10-29
Letter2014-07-29
Label2007-07-16
Label2012-10-26
Label2014-07-11
Label2014-07-29
Letter2005-01-13
Letter2014-07-11
Medication Guide2012-10-29
Other Important Information from FDA2007-05-09
Label2005-01-13

Application Sponsors

NDA 017090SPECGX LLC

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001CAPSULE;ORALEQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1TOFRANIL-PMIMIPRAMINE PAMOATE
002CAPSULE;ORALEQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1TOFRANIL-PMIMIPRAMINE PAMOATE
003CAPSULE;ORALEQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1TOFRANIL-PMIMIPRAMINE PAMOATE
004CAPSULE;ORALEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1TOFRANIL-PMIMIPRAMINE PAMOATE

FDA Submissions

TYPE 2; Type 2 - New Active IngredientORIG1AP1973-03-11STANDARD
REMS; REMSSUPPL6AP1974-05-22STANDARD
REMS; REMSSUPPL7AP1974-05-22STANDARD
REMS; REMSSUPPL8AP1974-05-22STANDARD
REMS; REMSSUPPL9AP1974-05-22STANDARD
REMS; REMSSUPPL10AP1974-05-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1974-05-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1974-05-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1974-05-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1974-05-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1974-05-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1974-05-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1974-06-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1975-12-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1977-06-07STANDARD
LABELING; LabelingSUPPL32AP1979-01-02
MANUF (CMC); Manufacturing (CMC)SUPPL33AP1979-12-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL34AP1979-12-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL35AP1979-06-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL36AP1979-06-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL37AP1980-01-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL38AP1980-04-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL39AP1980-04-16STANDARD
LABELING; LabelingSUPPL40AP1981-02-04
MANUF (CMC); Manufacturing (CMC)SUPPL41AP1986-07-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL42AP1983-05-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL44AP1984-11-05STANDARD
LABELING; LabelingSUPPL45AP1984-03-26
MANUF (CMC); Manufacturing (CMC)SUPPL46AP1984-10-29STANDARD
LABELING; LabelingSUPPL47AP1985-04-26
MANUF (CMC); Manufacturing (CMC)SUPPL48AP1985-05-05STANDARD
LABELING; LabelingSUPPL49AP1985-11-27
MANUF (CMC); Manufacturing (CMC)SUPPL50AP1986-05-20STANDARD
EFFICACY; EfficacySUPPL51AP1987-08-12
MANUF (CMC); Manufacturing (CMC)SUPPL52AP1989-04-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL53AP1989-08-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL54AP1989-10-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL55AP1989-10-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL56AP1990-04-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL57AP1991-08-02STANDARD
LABELING; LabelingSUPPL58AP1992-12-08
MANUF (CMC); Manufacturing (CMC)SUPPL59AP1993-02-19STANDARD
LABELING; LabelingSUPPL60AP2000-03-27STANDARD
LABELING; LabelingSUPPL61AP2000-03-27STANDARD
LABELING; LabelingSUPPL62AP2000-03-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL63AP1997-07-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL64AP1999-04-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL65AP2000-04-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL66AP2000-06-21STANDARD
LABELING; LabelingSUPPL67AP2002-01-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL68AP2002-06-20STANDARD
LABELING; LabelingSUPPL69AP2004-03-26STANDARD
LABELING; LabelingSUPPL70AP2005-01-12STANDARD
LABELING; LabelingSUPPL74AP2007-07-13STANDARD
LABELING; LabelingSUPPL76AP2012-10-26STANDARD
LABELING; LabelingSUPPL77AP2014-07-10901 REQUIRED
LABELING; LabelingSUPPL78AP2014-07-28STANDARD

Submissions Property Types

SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL19Null0
SUPPL23Null0
SUPPL25Null0
SUPPL33Null0
SUPPL34Null0
SUPPL35Null0
SUPPL36Null0
SUPPL37Null0
SUPPL38Null0
SUPPL39Null0
SUPPL41Null0
SUPPL42Null0
SUPPL44Null0
SUPPL46Null0
SUPPL48Null0
SUPPL50Null0
SUPPL52Null0
SUPPL53Null0
SUPPL54Null0
SUPPL55Null0
SUPPL56Null0
SUPPL57Null0
SUPPL59Null0
SUPPL63Null0
SUPPL64Null0
SUPPL65Null0
SUPPL66Null0
SUPPL68Null0
SUPPL76Null15
SUPPL77Null6
SUPPL78Null6

CDER Filings

SPECGX LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 17090
            [companyName] => SPECGX LLC
            [docInserts] => ["Medication Guide","http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM326090.pdf"]
            [products] => [{"drugName":"TOFRANIL-PM","activeIngredients":"IMIPRAMINE PAMOATE","strength":"EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"TOFRANIL-PM","activeIngredients":"IMIPRAMINE PAMOATE","strength":"EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"TOFRANIL-PM","activeIngredients":"IMIPRAMINE PAMOATE","strength":"EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"TOFRANIL-PM","activeIngredients":"IMIPRAMINE PAMOATE","strength":"EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"07\/28\/2014","submission":"SUPPL-78","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/017090s078lbl.pdf\"}]","notes":""},{"actionDate":"07\/10\/2014","submission":"SUPPL-77","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/017090s077lbl.pdf\"}]","notes":""},{"actionDate":"10\/26\/2012","submission":"SUPPL-76","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/017090s076lbl.pdf\"}]","notes":""},{"actionDate":"07\/13\/2007","submission":"SUPPL-74","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/017090s74lbl.pdf\"}]","notes":""},{"actionDate":"01\/12\/2005","submission":"SUPPL-70","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/17090s070lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"TOFRANIL-PM","submission":"IMIPRAMINE PAMOATE","actionType":"EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"TOFRANIL-PM","submission":"IMIPRAMINE PAMOATE","actionType":"EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"TOFRANIL-PM","submission":"IMIPRAMINE PAMOATE","actionType":"EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"TOFRANIL-PM","submission":"IMIPRAMINE PAMOATE","actionType":"EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2014-07-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.